Assessment the level of Urinary nephrin as an early biomarker in Diabetic Nephropathy
University of Thi-Qar Journal Of Medicine · 14.12.2025 · 29 (2) · 76-81
DOI: 10.32792/jmed.2025.29.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift University of Thi-Qar Journal Of Medicine, online erschienen am 14.12.2025. Verfasst von Kanaan Faisal Yassin und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Most people with diabetes have hyperglycemia, or uncontrolled blood sugar, which can lead to a number of dangerous side effects, such as diabetic nephropathy. Finding new indicators that can give early diagnosis and prevent consequences has become more crucial as a result of the lack of early detection. Many kidney disorders originate and advance as a result of damage or dysfunction to podocyte cells. This increases the possibility of employing podocyte cell product targets, particularly in urine, as practical clinical markers for kidney disease diagnosis and surveillance. A cross-sectional study will be carried out to a group of 70 diabetic patients with diabetic nephropathy 20 healthy control. A total of 25 mL urine was collected. Alb/Cr ratio in a random urine sample . Serum creatinine, serum albumin and HbA1C. Urinary Albumin / creatinine ratio. Urinary podocalyxin, nephrin and podocin were determined by using commercially available ELISA test. According to the study, 50% of patients with normoalbuminuria have greater urine Nephrin levels than the healthy control group. Nephrin levels are also higher in the former group. These results imply that Nephrin initially manifests in the urine before microalbumin in the early stages of kidney injury. According to the data, both the UM/CR and CKD staging categories had significantly higher urine nephrin levels than the healthy control group. Urinary nephrin levels gradually increased with CKD stage, particularly in stages two and three, and it was shown that urine nephrin was more sensitive than the UM/CR ratio for early kidney damage identification. Diabetes patients had much greater amounts of nephrin, and podocalxyin in their urine compared to the healthy control group.
Zitieren
APA
Yassin, K. F., & Zbaar, S. A. (2025). Assessment the level of Urinary nephrin as an early biomarker in Diabetic Nephropathy. University of Thi-Qar Journal Of Medicine, 29(2), 76-81. https://doi.org/10.32792/jmed.2025.29.26
Vancouver
Yassin KF, Zbaar SA. Assessment the level of Urinary nephrin as an early biomarker in Diabetic Nephropathy. University of Thi-Qar Journal Of Medicine. 2025;29(2):76-81. doi:10.32792/jmed.2025.29.26
BibTeX
@article{Yassin2025,
author = {Yassin, Kanaan Faisal and Zbaar, Sami A},
title = {Assessment the level of Urinary nephrin as an early biomarker in Diabetic Nephropathy},
journal = {University of Thi-Qar Journal Of Medicine},
year = {2025},
volume = {29},
number = {2},
pages = {76--81},
doi = {10.32792/jmed.2025.29.26}
}
EUVIMED